Danone today announced a new phase of investment in Danone's Digital Lab (D-Lab) in Singapore, reinforcing the company's commitment to advancing digital health innovation and expanding its global research and innovation (R&I) footprint.
Danone will accelerate the D-Lab's capabilities in digital science, data analytics, and Al driven health solutions with a particular focus on healthy nutrition for an aging population - a growing public health priority in the region. Danone will advance the delivery of science based, consumer-centric innovations that are tailored to regional needs and scalable globally.
This reflects the long-standing partnership between Danone and the Singapore Economic Development Board (EDB), including a joint initiative linked to digital health in 2018 that was launched at the time of the inauguration of Danone's OneBiome Lab Singapore with a focus on studying the gut microbiome. With the support of EDB, the Agency of Science, Technology and Research (NSTAR) and other local institutions, Danone has built and grown a thriving ecosystem in Singapore to advance digital health services. These services, which enable early screening, continuous monitoring, and nutritional management of health conditions, are now serving as a model to be rolled out and scaled globally.